Masters, Elysia A. http://orcid.org/0000-0002-9981-624X
Trombetta, Ryan P.
de Mesy Bentley, Karen L.
Boyce, Brendan F
Gill, Ann Lindley
Gill, Steven R.
Nishitani, Kohei
Ishikawa, Masahiro
Morita, Yugo
Ito, Hiromu
Bello-Irizarry, Sheila N.
Ninomiya, Mark
Brodell, James D. Jr.
Lee, Charles C.
Hao, Stephanie P.
Oh, Irvin
Xie, Chao
Awad, Hani A.
Daiss, John L.
Owen, John R.
Kates, Stephen L.
Schwarz, Edward M. http://orcid.org/0000-0002-4854-9698
Muthukrishnan, Gowrishankar http://orcid.org/0000-0001-7521-6154
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50 AR072000, P30 AR069655, R01 AR43510, R01 AG049994, P30 AR061307, T32 AR53459, R21 AR074571, R21 AR073321, R21 AR073321, R21 AR500710, P30 AR069655-01 Pilot, P50 AR072000, P30 AR069655, R01 AI119646, P50 AR072000, P30 AR069655)
AO Foundation (Clinical Priority Program, Clinical Priority Program, Clinical Priority Program)
Amedica Inc
Bristol-Myers Squibb
Astellas Pharma
Asahi Kasei Pharma Corporation
Bristol-Myers, Astellas and Asahi-Kasei
Goldstein Award from the Department of Orthopaedics, University of Rochester, Rochester, NY
Article History
Received: 2 April 2019
Revised: 17 June 2019
Accepted: 21 June 2019
First Online: 15 July 2019
Competing interests
: The authors declare no competing interests.